Journal Club

Here is a review article by Ko, Diep and Lam on a new technology using portable translingual neurostimulation for stroke, balance disorders and other chronic neurological conditions.

Introduction: There is a paucity of long-term treatment benefit and safety data of botulinum toxin A (BTX-A) for cervical dystonia (CD) and myofascial neck pain syndrome (MPS). Additionally, the prevalence of adjunct modality uses during this period is unknown despite evolving practices.